Sentinel lymph node biopsy (SLNB) has replaced conventional axillary lymph node dissection (ALND) in axillary node-negative breast cancer patients. However, the use of SLNB remains controversial in patients after neoadjuvant chemotherapy (NAC). The aim of this review is to evaluate the feasibility and accuracy of SLNB after NAC in clinically node-positive patients. Systematic searches were perf...

BACKGROUND Although sentinel lymph node biopsy (SLNB) is the most sensitive and accurate investigative modality for establishing regional node status in patients with melanoma, its role and benefit in melanoma of different Breslow's thickness is still controversial. OBJECTIVE The current study aimed mainly to evaluate the effects of SLNB results on important outcome parameters in primary mela...

HYPOTHESIS Certain primary breast tumor characteristics can be used to predict positive sentinel lymph node biopsy (SLNB) results and thus determine which patients should undergo SLNB. DESIGN Retrospective review of patients undergoing SLNB for invasive breast cancer from March 1, 1998, through March 31, 2001. SETTING University-affiliated tertiary care hospital. PATIENTS Two hundred fift...

OBJECTIVES/HYPOTHESIS Sentinel lymph node biopsy (SLNB) is considered one of the most important melanoma advancements to date. Since its inception in 1992, a plethora of data and associated controversies has emerged leading to the question: Is SLNB considered the standard of care for head and neck (HN) cutaneous melanoma? STUDY DESIGN English literature (1990-2014) review. METHODS The PubMe...

BACKGROUND Previous studies have demonstrated that mastoscopic sentinel lymph node biopsy (MSLNB) has good identification rate (IR) and low false negative rate (FNR). However, few studies have directly compared the surgical performance and peri- and post-operative factors of MSLNB with conventional sentinel lymph node biopsy (SLNB). METHODOLOGY Sixty patients diagnosed with breast cancer were...

PURPOSE Sentinel lymph node biopsy (SLNB) is an accurate and effective means of axillary nodal staging in early breast cancer. However its indication after neoadjuvant chemotherapy (NAC) is under constant debate. The present study evaluates the reliability of SLNB in assessing axillary nodal status after NAC. METHODS Data from 281 patients who had received NAC and subsequent SLNB were reviewe...

Received June 5, 2003; revision received October 30, 2003; accepted November 4, 2003. BACKGROUND. Desmoplastic and neurotropic melanoma (DNMM) occasionally metastasizes to regional lymph nodes and extranodal sites. The value of sentinel lymph node biopsy (SLNB) has not been demonstrated clearly for patients with DNMM. The authors report on the utility of SLNB in the management of patients with ...

BACKGROUND Sentinel lymph node biopsy (SLNB) is rapidly gaining acceptance as a diagnostic tool for staging breast cancer. OBJECTIVE Analyze trends among surgeons and facilities in Kaiser Permanente Northern California (KPNC) in adopting SLNB to stage cases of breast cancer and assess success in locating the sentinel node. METHODS Retrospective review of data for patients whose breast cance...

Background. Being predictive of the entire nodal bed, sentinel lymph node biopsy (SLNB) is invaluable in the surgical management of melanoma. Although the concept is simple, sentinel lymph node (SLN) identification and removal can be technically challenging. Methods. A total of 102 consecutive patients have undergone SLNB in the Division of Plastic and Reconstructive Surgery of Soroka Universit...

Abstract Aim To assess the management of sentinel lymph node biopsy (SLNB) in patients with a pre-operative B5c histopathological diagnosis. Method A retrospective study decision for SLNB 31 breast cancer and their final histology were reviewed between 2009-2019. Factors that determine concurrent (size mass lesion > 1cm/increasing size, DCIS 4cm, recurrence abnormal nodes on ultrasound) ...